Eupraxia Pharmaceuticals Inc. (EPRX)
Market Open
3 Mar, 16:15
NASDAQ (CM) NASDAQ (CM) Primary 
TSX $
8. 21
-0.09
-1.08%
$
273.87M Market Cap
- P/E Ratio
- Div Yield
30,111 Volume
- Eps
$ 8.3
Previous Close Day Range
8.07 8.21
Year Range
2.68 9.32
Want to track EPRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
EPRX earnings report is expected in 16 days (19 Mar 2026)
Wall Street Analysts Think Eupraxia Pharmaceuticals Inc. (EPRX) Could Surge 75.08%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 75.1% in Eupraxia Pharmaceuticals Inc. (EPRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks | 3 months ago
Wall Street Analysts Believe Eupraxia Pharmaceuticals Inc. (EPRX) Could Rally 85.12%: Here's is How to Trade
The consensus price target hints at an 85.1% upside potential for Eupraxia Pharmaceuticals Inc. (EPRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks | 4 months ago
